Infection Control Market (By Product & Service: Sterilization Products and Services, Cleaning and Disinfection Products, Protective Barriers, Endoscope Reprocessing Products, Other Infection Control Products; By End User: Hospitals & Clinics, Medical Device Companies, Pharmaceutical Companies, Life Science Industry, Food Industry, Other End Users) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024 – 2033
The global infection control market size was estimated at USD 233.35 billion in 2023 and it is projected to surpass around USD 446.33 billion by 2033, growing at a CAGR of 6.7% during the estimated time frame 2024 to 2033. The main cause of infections is microorganisms like fungi, bacteria, viruses, etc. There are various kinds of infections associated with various parts of body like infections related to skin, stomach, lungs, eyes, intestine, ear, and others. The reason behind these infections may be the infection caused due to equipment, due to the surrounding audience, among others. For the treatment of these infections, various products like disinfectants, protective equipment, etc. are available in the market to treat them as well as to get rid of them.
To Access our Exclusive Data Intelligence Tool with 15000+ Database, Visit: Precedence Statistics
The U.S. infection control market size was estimated at USD 55.87 billion in 2023 and is predicted to be worth around USD 113.29 billion by 2033, at a CAGR of 7.3% from 2024 to 2033.
North America accounted for 34.14% of revenue share in 2023. The locale's enormous offer can be credited to the developing interest for and reception of cleansing and sanitization items alongside administrations because of the rising spotlight on solid ways of life and sickness counteraction among customers. The flood in the geriatric populace before long and the ensuing expansion in the predominance of ongoing illnesses, the requirement for infection control to limit the pervasiveness of HAIs, and the execution of positive government drives and rigid guidelines on sanitization and sterilization are likewise pushing the disease control market in the area.
In the Asia Pacific, the market for infection control is supposed to show the quickest CAGR all through the estimated period inferable from the developing presence of rethinking associations, developing medical services consumption, and phenomenal advancement of medical care guidelines and foundation across this district. The presence of different deliberate and government associations zeroed in on further developing disease control norms is additionally one of the huge variables adding to the development of the Asia Pacific area. Expanding pattern of re-appropriating by laid out market players in created economies, to organizations in the Asia Pacific locale, additionally fills in as key development inducing factor for the market. For example, the Asia Pacific Society of Infection Control (APSIC) is a deliberate association working toward laying out cooperative organizations to work with quality improvement and direct infection control examination to advance expense productive practices all through the Asia Pacific locale.
Hospital-acquired infections (HAIs) are nosocomial contaminations that happen during a patient's visit to medical clinics and related offices and are not seen at the hour of confirmation. They are a significant reason for horribleness and mortality around the world. These contaminations incorporate focal line-related circulatory system diseases, careful site diseases, catheter-related urinary parcel contaminations, medical clinic procured pneumonia, ventilator-related pneumonia, and Clostridium difficile contaminations. The most well-known microscopic organisms related to HAIs incorporate C. difficile, MRSA, Klebsiella, E. coli, Enterococcus, and the Pseudomonas species. Utilizing tainted clinical gadgets during indicative and restorative methods is a significant reason for HAIs. As per the CDC, up to 1.7 million hospitalized patients in the US every year get medical care-related contaminations (HCAIs) while being treated for other medical problems, and more than 98,000 of these patients (one out of 17) pass on because of HCAIs. 32% of all HAIs in the nation are urinary plot contaminations, 22% are careful site diseases, 15% are lung (pneumonia) diseases, and 14% are circulatory system diseases. This is supposed to support the interest in sanitization and sanitizer items.
The occurrence of HAIs is predominantly subject to the patient's resistant status, disease control rehearses, and the commonness of different irresistible specialists in the medical services office. Different elements incorporate longer medical clinic stays, immunosuppression, more seasoned age, and stays in concentrated care units. Around 20% of such diseases happen in ICUs. The significant microorganisms causing HAIs to incorporate C. difficile, Staphylococcus aureus, Klebsiella, and Escherichia coli. The flare-up of COVID-19 and the developing instances of local area transmission diseases recognized in medical care faculty (HCP) has prompted the execution of rules for infection control by different government bodies across the globe. Considering such turns of events, the interest ininfection control practices, for example, the legitimate utilization of cleansing and sanitizer items is supposed to increment in medical care offices across the globe before long.
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 6.7% |
| Market Size in 2023 | USD 233.35 Billion |
| Market Size by 2033 | USD 446.33 Billion |
| Largest Market | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product & Service, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Toxic Properties of Chemical Disinfectants to Lower Its Sales
There are many chemical disinfectants which are readily available in the market possess poisonous properties. For instance, sodium hypochlorite (NaCIO) cures blood rode pathogens effectively. But this compound is extremely acidic in nature and is annoying to the respiratory system. This can turn harmful for cleaning workers and residents of the particular building as well as poisonous when expelled into the locality. An inappropriate usage of these products may trigger environmental risks and be dangerous to individuals coming in contact with it. Disinfectants have got no green certificate till the date. Disinfectants used in the Unites States should have the registered mark of Environmental Protection Agency (EPA), and these disinfectants are administered through the act Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). As the populace is in the demand of greener solutions, the usage of these products is getting restricted. Producers of these products are now being enforced to look upon the greener and advanced options which will not be harmful to the human body.
Increasing Implementation of Single-Use Products
Old age populace across the globe is increasing and the propensity of diabetes and obesity is also rising, which in turn is giving rise to the increasing number of surgical procedures yearly. The increasing number of surgical procedures grew the demand for single-use medical products which are easily able to dispose of immediately after the usage or disposable ones. Healthcare spending per person is augmenting and the significance of hygiene maintenance and cleanliness is rising. These factors are anticipated to upsurge the demand for single-use nonwoven medical products. Various viral diseases like Ebola, Zica virus, dengue, and yellow fever and the pandemic have outspreaded in the past few years. These diseases have also bolstered the demand for these single-use products. Protective apparel market will also witness a considerable growth as the hospitals are focusing more on lowering the rate of Healthcare Associated Infections (HAIs). Thus, all these factors offer lucrative opportunities to the global market to for its growth over the forecast period.
The protective barriers market represented the biggest portion of the infection control market in 2023. The enormous portion of the defensive boundaries market can be credited to the rising reception of clinical nonwovens, for example, facial coverings and careful curtains and outfits, because of the ongoing ascent in COVID-19 cases. The medical clinics and facilities end-client portion is supposed to represent the biggest portion of the disease control market.
The medical clinics and facilities portion represented the biggest portion of the infection control market in 2023. The general interest ininfection control in clinics is to a great extent driven by the rising pervasiveness of HAIs, the rising number of clinics and facilities around the world, and the rising geriatric populace (as this populace section is more defenseless to different ongoing sicknesses). The developing volume of surgeries performed is additionally a significant supporter of the development of the disease control market for clinics. The rising number of government drives to guarantee serious level disease avoidance is additionally a critical driver of the market fragment. The hospitals segment accounted for 40% revenue share in 2023.
COVID-19 Surged the Demand for Self-Protective Equipment
The demand for advanced facilities of healthcare and infrastructure has surged in a drastic manner as the COVID-19 was outspreading across the world. The demand for infection control goods like self-safeguarding equipment has burgeoned across all the nations to manage the outburst of this pandemic, as these good are one of the important parts of healthcare. Healthcare professionals were dependent on this self-safeguarding equipment to take care of themselves and all the patients coming in their contact. However, the pandemic was outspreading like fire in the jungle, accessibility of these products became insufficient and the healthcare sector has to witness downfall in terms of numbers. According to the World Health Organization (WHO), the number of masks required every month was approximately 89 million. The gloves employed for the examination went nearly to 76 million per month. China is the global leader in manufacturing and exporting masks. In addition, the demand for aerosol disinfectants grew up by almost 32%. As per the estimation of WHO, healthcare professionals needed around 7% to 10% of the whole global supply of surgical masks, and this percentage can even grow more looking towards the outbreak of this pandemic. In addition, according to their estimates the sale for medical masks grew by nearly 319% as well as the sale of maintenance masks uplifted by approximately 262%. COVID-19 became a point of attraction for the individuals to purchase self-protective equipment and the usage of single-use equipment, thus marking a positive impact on the global infection control market.
Segments Covered in the Report
By Product & Service
By End User
By Geography
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
